Home / Tobramycin / United States
US ATC J01GB01 · updated 2 Nov 2026
Tobramycin shortage in United States
Is there a Tobramycin shortage in United States?
Yes. As of 2 Nov 2026, 1 Tobramycin product is reported short in United States, the first since 17 Jul 2026. No return date has been given. Main reason: not stated.
Also short in Canada, Germany, Italy, Sweden. All countries.
Affected products in United States
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| US | Tobramycin Sulfate, Injection, 80 mg/2 mL (40 mg/mL); 2 mL Multiple Dose Glass Fliptop Vial (NDC 0409-3578-01) discontinuation | Hospira, Inc., a Pfizer Company | 17 Jul 2026 | not given | Not stated |
Source
U.S. Food and Drug Administration (FDA), Drug Shortages via openFDA. Official list. Shortages the FDA lists as current, plus products to be discontinued; one row per package (NDC).